• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性硬化中的单核细胞激活

Monocyte activation in multiple sclerosis.

作者信息

Reder A T, Genç K, Byskosh P V, Porrini A M

机构信息

Department of Neurology, University of Chicago, Illinois 60637, USA.

出版信息

Mult Scler. 1998 Jun;4(3):162-8. doi: 10.1177/135245859800400314.

DOI:10.1177/135245859800400314
PMID:9762667
Abstract

Monocytes, macrophages, and microglia have a central role in the CNS inflammation of MS. Monocytes are important in the earliest events in MS. Peripheral blood monocytes secrete prostaglandins before MS attacks. During clinical activity monocyte activation markers increase and IL-1 and TNF-alpha levels are elevated. Other monocyte products such as IL-10 reduce inflammation. IL-10 mRNA in MNC is increased during stable disease. Manipulation of monokine secretion and expression of monocyte surface proteins are reasonable approaches for immune therapy of MS.

摘要

单核细胞、巨噬细胞和小胶质细胞在多发性硬化症的中枢神经系统炎症中起核心作用。单核细胞在多发性硬化症的早期事件中很重要。外周血单核细胞在多发性硬化症发作前分泌前列腺素。在临床活动期间,单核细胞激活标志物增加,白细胞介素-1和肿瘤坏死因子-α水平升高。其他单核细胞产物如白细胞介素-10可减轻炎症。在疾病稳定期,单核细胞中的白细胞介素-10信使核糖核酸增加。操纵单核因子分泌和单核细胞表面蛋白的表达是多发性硬化症免疫治疗的合理方法。

相似文献

1
Monocyte activation in multiple sclerosis.多发性硬化中的单核细胞激活
Mult Scler. 1998 Jun;4(3):162-8. doi: 10.1177/135245859800400314.
2
Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.β干扰素增强B7-H1(程序性死亡配体1)在单核细胞和树突状细胞中的表达,B7-H1是自体T细胞活化的强效抑制剂:对多发性硬化症免疫调节作用的相关性。
J Neuroimmunol. 2004 Oct;155(1-2):172-82. doi: 10.1016/j.jneuroim.2004.06.013.
3
Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis.γ干扰素、白细胞介素-4及转化生长因子-β mRNA在多发性硬化症和重症肌无力中的表达
Acta Neurol Scand Suppl. 1994;158:1-58.
4
T cell lymphokine-induced secretion of cytokines by monocytes from patients with multiple sclerosis.T细胞淋巴因子诱导多发性硬化症患者单核细胞分泌细胞因子。
Cell Immunol. 1993 Jan;146(1):96-106. doi: 10.1006/cimm.1993.1009.
5
Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.单核细胞衍生的HLA-G作为自体CD4 T细胞活化的强力抑制剂,在体外和体内均被β干扰素上调:多发性硬化症治疗的理论依据。
J Neuroimmunol. 2005 Feb;159(1-2):155-64. doi: 10.1016/j.jneuroim.2004.09.016. Epub 2004 Dec 28.
6
GM-CSF promotes migration of human monocytes across the blood brain barrier.GM-CSF 促进人单核细胞穿过血脑屏障的迁移。
Eur J Immunol. 2015 Jun;45(6):1808-19. doi: 10.1002/eji.201444960. Epub 2015 May 3.
7
Increased CXCL8 (IL-8) expression in Multiple Sclerosis.
J Neuroimmunol. 2004 Oct;155(1-2):161-71. doi: 10.1016/j.jneuroim.2004.06.008.
8
Elevated endothelial microparticle-monocyte complexes induced by multiple sclerosis plasma and the inhibitory effects of interferon-beta 1b on release of endothelial microparticles, formation and transendothelial migration of monocyte-endothelial microparticle complexes.多发性硬化症血浆诱导的内皮微粒-单核细胞复合物升高以及β-1b干扰素对内皮微粒释放、单核细胞-内皮微粒复合物形成和跨内皮迁移的抑制作用。
Mult Scler. 2005 Jun;11(3):310-5. doi: 10.1191/1352458505ms1184oa.
9
Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administration.多发性硬化症严重复发实验大鼠模型中单核细胞 M1/M2 激活模式的改变。M2 激活的单核细胞给药改善临床状况。
Mult Scler. 2011 Jan;17(1):2-15. doi: 10.1177/1352458510379243. Epub 2010 Sep 2.
10
Interferon-beta up-regulates the expression of co-stimulatory molecules CD80, CD86 and CD40 on monocytes: significance for treatment of multiple sclerosis.β-干扰素上调单核细胞上共刺激分子CD80、CD86和CD40的表达:对多发性硬化症治疗的意义
Clin Exp Immunol. 2004 Dec;138(3):499-506. doi: 10.1111/j.1365-2249.2004.02624.x.

引用本文的文献

1
Myelopoiesis is temporally dynamic and is regulated by lifestyle to modify multiple sclerosis.骨髓生成具有时间动态性,并受生活方式调节以改变多发性硬化症。
Nat Commun. 2025 Apr 17;16(1):3683. doi: 10.1038/s41467-025-59074-w.
2
Immunomodulatory Potential of a Bibenzyl-dihydrophenanthrene Derivative Isolated from .从……中分离出的一种联苄-二氢菲衍生物的免疫调节潜力
J Nat Prod. 2025 Feb 28;88(2):537-545. doi: 10.1021/acs.jnatprod.4c01394. Epub 2025 Jan 29.
3
Hematopoietic anomalies fuels multiple sclerosis.造血异常引发多发性硬化症。
Life Med. 2022 Jul 1;1(2):52-54. doi: 10.1093/lifemedi/lnac019. eCollection 2022 Oct.
4
Myeloid-derived Suppressor Cells and Multiple Sclerosis.髓系来源抑制细胞与多发性硬化症。
Curr Neuropharmacol. 2024;23(1):36-57. doi: 10.2174/1570159X22999240710142942.
5
Causal association between the peripheral immunity and the risk and disease severity of multiple sclerosis.外周免疫与多发性硬化症的风险和疾病严重程度之间的因果关联。
Front Immunol. 2024 Feb 8;15:1325938. doi: 10.3389/fimmu.2024.1325938. eCollection 2024.
6
Oral Cladribine Impairs Intermediate, but Not Conventional, Monocyte Transmigration in Multiple Sclerosis Patients across a Model Blood-Brain Barrier.口服克拉屈滨可损害多发性硬化症患者模型血脑屏障中中间但非传统的单核细胞迁移。
Int J Mol Sci. 2023 Mar 30;24(7):6487. doi: 10.3390/ijms24076487.
7
The dynamic inflammatory profile of pregnancy can be monitored using a novel lipid-based mass spectrometry technique.利用新型基于脂质的质谱技术可以监测妊娠时的动态炎症谱。
Mol Omics. 2023 May 9;19(4):340-350. doi: 10.1039/d2mo00294a.
8
Immunological Subsets Characterization in Newly Diagnosed Relapsing-Remitting Multiple Sclerosis.新发复发型多发性硬化的免疫学亚群特征。
Front Immunol. 2022 Feb 22;13:819136. doi: 10.3389/fimmu.2022.819136. eCollection 2022.
9
The Roles of Monocyte and Monocyte-Derived Macrophages in Common Brain Disorders.单核细胞和单核细胞衍生的巨噬细胞在常见脑部疾病中的作用。
Biomed Res Int. 2020 Jun 4;2020:9396021. doi: 10.1155/2020/9396021. eCollection 2020.
10
Expansion of Neutrophils and Classical and Nonclassical Monocytes as a Hallmark in Relapsing-Remitting Multiple Sclerosis.中性粒细胞和经典及非经典单核细胞的扩增是复发缓解型多发性硬化症的特征之一。
Front Immunol. 2020 Apr 29;11:594. doi: 10.3389/fimmu.2020.00594. eCollection 2020.